MyAverix Finance MyAverix Finance

TA · Financials

Israel China Biotechnology (ICB) Ltd (ICB)

Investment Banking & Investment Services

Israel China Biotechnology (ICB) Ltd (ICB) is listed on TA in the Financials sector. Industry: Investment Banking & Investment Services. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for ICB

P/E ratio
18.00

Israel China Biotechnology (ICB) Ltd (ICB) — FAQ

What is ICB's P/E ratio?

The price-to-earnings (P/E) ratio for Israel China Biotechnology (ICB) Ltd (ICB) is 18.00 (data as of 2026-05-24).

Does Israel China Biotechnology (ICB) Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Israel China Biotechnology (ICB) Ltd (ICB). Check the MyAverix Finance app for the latest dividend data.

What sector is Israel China Biotechnology (ICB) Ltd in?

Israel China Biotechnology (ICB) Ltd (ICB) is classified in the Financials sector (Investment Banking & Investment Services industry).

What exchange is ICB listed on?

ICB is listed on TA.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play